196
Participants
Start Date
September 9, 2014
Primary Completion Date
September 3, 2020
Study Completion Date
September 16, 2020
Ondansetron
Pregnant women may receive a second dose of IV ondansetron if they have not delivered within 4 hours of receiving the IV study medication. 50% of the 90 mother/baby pairs will receive ondansetron; the baby will always get the same study medication as the mother.
Placebo
All doses of placebo, whether IV or oral, will mimic the same volume as the ondansetron group to maintain the blind. Pregnant women may receive a second dose of IV placebo if they have not delivered within 4 hours of being given the IV study medication. 50% of the 90 mother/baby pairs will receive placebo; the baby will always receive the same study medication as the mother.
Thomas Jefferson University Hospital, Philadelphia
Johns Hopkins Bayview Medical Center, Baltimore
University of Tennessee Health Science Center, Memphis
University of Louisville, Louisville
The University of Utah, Salt Lake City
UCSF, San Francisco General Hospital, San Francisco
Stanford University Medical Center, Stanford
Santa Clara Valley Medical Center, San Jose
Santa Clara Valley Medical Center
OTHER
Thomas Jefferson University
OTHER
Stanford University
OTHER